GoodRx Holdings, Inc. (GDRX) vs SOPHiA GENETICS SA (SOPH)
GoodRx Holdings, Inc. and SOPHiA GENETICS SA are both Health Information Services companies. GoodRx Holdings, Inc. is the larger, with a market value of $1.2B against $703.2M — 1.6× the size. SOPHiA GENETICS SA has negative trailing earnings, so its P/E is not meaningful; GoodRx Holdings, Inc. trades at 62.5×. SOPHiA GENETICS SA grew revenue faster over the last twelve months: 23.7% against −1.83%. GoodRx Holdings, Inc. has the higher net margin (2.07% vs −93.9%) and the higher return on invested capital (5.59% vs −196.5%). Across the 18 metrics below, GoodRx Holdings, Inc. leads on 13 and SOPHiA GENETICS SA on 5.
Valuation
Profitability
| Metric | GDRX | SOPH | Health Information Services median |
|---|---|---|---|
| Gross margin | 90.83% | 66.63% | 63.38% |
| Operating margin | 9.54% | (85.55%) | (8.35%) |
| Net margin | 2.07% | (93.86%) | (14.70%) |
| Free cash flow margin | 16.77% | (47.83%) | 0.58% |
| Return on equity | 2.52% | (101.22%) | (6.82%) |
| Return on assets | 0.89% | (43.02%) | (6.02%) |
| Return on invested capital | 5.59% | (196.45%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack